Screen, isolate and optimise best lead compounds
Perform pharmacological studies in relevant models
Find optimal formulation and most adapted drug delivery system
Obtain clinical trial authorisation for First in Human studies

Unmet medical needs

Therapeutics that directly and specifically target the enzymes modifying the microtubules, have so far never been explored. The solutions being developed by MT-act are therefore unique in the healthcare landscape and open the road to a novel class of medication.

Pioneering new therapeutics

The most efficient lead compounds in our hands will be formulated for the best administration routes answering the needs of clinicians, while taking in account the comfort of the patients. Our approach goes beyond state-of-the-art, and holds the potential to be clinically beneficial in areas of medicine with high unmet medical needs.